Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(20):1497; doi:10.1093/jnci/djm197
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Androgen Deprivation Therapy and the Risk of Cardiovascular Death

Androgen deprivation therapy (ADT) may increase the risk of coronary artery disease. Tsai et al. (p. 1516) investigated the relationship between ADT use and the risk of death from cardiovascular causes in patients with localized prostate cancer. Among patients 65 years or older treated with radical prostatectomy, ADT use was associated with a statistically significant increase in the risk of death from cardiovascular causes. The 5-year cumulative incidence of cardiovascular death was 5.5% among patients receiving ADT and 2.0% among those who did not. Among patients who . . . [Full Text of this Article]

Risk of Invasive Cancer in the WHI Dietary Modification Trial

Genetic Variants in Chromosome 8q24 and Prostate Cancer Risk

The Value of PSA Velocity in Prostate Cancer Screening

Association Between Allergies and Brain Cancer Risk

Targeting Tumor Endothelial Marker-8 with TEM8-Fc


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?